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Abstract
Background:  Glucose repression of transcription in the yeast, Saccharomyces cerevisiae, has been
shown to be controlled by several factors, including two repressors called Mig1 and Mig2. Past
results suggest that other repressors may be involved in glucose repression.
Results:  By a screen for factors that control transcription of the glucose-repressible SUC2 gene
of S. cerevisiae, the NRG1 gene was identified. Analysis of an nrg1∆  mutant has demonstrated that
mRNA levels are elevated at both the SUC2 and of the GAL genes of S. cerevisiae when cells are
grown under normally glucose-repressing conditions. In addition, genetic interactions have been
detected between nrg1∆  and other factors that control SUC2 transcription.
Conclusions:  The analysis of nrg1∆  demonstrates that Nrg1 plays a role in glucose repression of
the SUC2 and GAL genes of S. cerevisiae. Thus, three repressors, Nrg1, Mig1, and Mig2, are involved
as the downstream targets of the glucose signaling in S. cerevisiae.
Background
For the yeast Saccharomyces cerevisiae, glucose is the
preferred carbon source. When glucose is present in the
growth media, transcription of a large number of genes
encoding products involved in the metabolism of alter-
native carbon sources is repressed (for reviews, see
[1,2,3]. These genes include the GAL, SUC2, MAL and
STA genes, required, respectively, for the utilization of
galactose, sucrose/raffinose, maltose, and starch.
At many of these genes, glucose repression is mediated,
at least in part, by the glucose-dependent repressor Mig1,
a zinc-finger protein that binds in vitro to DNA consen-
sus sites consisting of a GC-rich core and flanking AT se-
quences [4, 5]. Mig1 is thought to bind to several
promoters, including GAL1, GAL4, SUC2 and MAL62,
and to effect transcriptional repression by interacting
with the co-repressor complex Ssn6-Tup1 [6,7,8]. Mig1's
activity is regulated by phosphorylation and subcellular
localization: in high glucose, Mig1 protein is hypophos-
phorylated and in the nucleus, where it can repress tran-
scription; upon withdrawal of glucose, Mig1 is rapidly
phosphorylated and transported into the cytoplasm [9].
This regulated phosphorylation requires the function of
the Snf1/Snf4 kinase complex [10].
Deletion of MIG1, however, only partially relieves glu-
cose repression at promoters such as SUC2, whereas de-
letion of either SSN6 or TUP1 completely abolishes
glucose repression. Moreover, the STA1 gene of S. cere-
visiae var. diastaticus, which is also repressed by glu-
cose, is unaffected by mig1∆  [11]. Therefore, other
proteins in addition to Mig1 are required for glucose re-
pression. One of these proteins is Mig2, which shares se-
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quence similarity with Mig1 in their zinc finger regions
[12, 13]. Genetic analysis suggests that Mig2 plays a mi-
nor role relative to Mig1.
Recently, a previously uncharacterized gene, NRG1
(Negative regulator of glucose-repressed genes), was
shown to be required for glucose repression of the STA1
gene in S. cerevisiae var. diastaticus [11]. These studies
demonstrated that LexA-Nrg1 behaves as a repressor of
a reporter construct and that this repression is depend-
ent on glucose, Ssn6, and Tup1. In addition, Nrg1 and
Ssn6 interact with each other in two-hybrid and GST
pull-down assays, indicating that Nrg1 may repress via
the same pathway as Mig1. Consistent with these results,
Nrg1 appears to bind to two sites within the STA1 pro-
moter.
The  SUC2 gene of S. cerevisiae has been extensively
studied with respect to its glucose repression [1,2]. Glu-
cose repression of SUC2 is mediated by Ssn6/Tup1 and
SUC2 has two Mig1 binding sites in its regulatory region.
Additionally, in high glucose its promoter is also occu-
pied by positioned nucleosomes, which cause transcrip-
tional repression themselves [14, 15]. Derepression in
low glucose is correlated with a loss of both Mig1- and
nucleosome-mediated repression, although the precise
relationship between the two pathways is not clear.
Genetic screens have identified a large number of genes,
named SNF (Sucrose Non-Fermenting) that are required
for derepression of SUC2 transcription in the absence of
glucose [16,17,18]. Genetic analyses and subsequent
studies have traditionally divided SNF genes into two
groups. One group encodes the protein kinase Snf1 and
its associated regulator Snf4, required to antagonize the
repression caused by Mig1 [10, 19]. The other group con-
sists of members of the Swi/Snf complex required to
counter the repressive effects of chromatin by remode-
ling nucleosomes in an ATP-dependent manner (for re-
view see [20]. Suppressors of swi/snf mutations, such as
spt6, do not suppress snf1∆  [21], and ssn6, a strong sup-
pressor of snf1∆ , only partially suppress swi/snf muta-
tions [22].
In this work, we report the identification of Nrg1 in a ge-
netic screen for new regulators of SUC2 transcription.
We show that Nrg1 plays a role in the glucose repression
of SUC2 and GAL genes in S. cerevisiae. Thus, at these
genes, Mig1, Mig2 and Nrg1 are partially redundant for
mediating repression by glucose. Consistent with our
findings, recent results have demonstrated an interac-
tion between Snf1 and Nrg1 [23]. We also present exper-
iments that test the genetic interactions between mig1∆ ,
nrg1∆  and deletions of various genes encoding activators
that function at the SUC2 promoter.
Results
Isolation of a high-copy-number suppressor of snf2∆
The Swi/Snf complex is required for normal levels of ex-
pression of SUC2 when cells are grown in low glucose. To
identify factors that might be functionally related to Swi/
Snf, we screened for high-copy-number plasmids that
could suppress a snf2∆  mutation (see Materials and
Methods). To sensitize the screen, we used an allele of
SUC2, SUC2-36, that allows an elevated level of SUC2
transcription in the absence of Swi/Snf [24]. The SUC2-
36 mutation is a single base pair change, AT to GC at po-
sition -401 relative to the SUC2 ATG. SUC2-36 strains
still have a Raf- phenotype in a snf2∆  mutant.
To identify high-copy-number suppressor candidates,
we used a 2µ  circle library to transform the snf2∆  SUC2-
36 strain FY1845 (Table 1) and screened 60,000 trans-
formants for those with a Raf+ phenotype. Eighty-two
candidates were identified, 25 of which contained the
SNF2 gene. Among the remaining plasmids, most con-
ferred a weak Raf+ phenotype. We focused on the candi-
date that conferred the strongest Raf+ phenotype. This
plasmid contained a chromosome IV genomic fragment
that spans from within the NRG1 gene (open reading
frame YDR043C) through the HEM12 gene (YDR047W).
Subcloning experiments identified the partial NRG1
clone as the sequence responsible for suppression of
snf2∆  and demonstrated that this suppression occurred
in both SUC2-36 and SUC2 + genetic backgrounds (Fig-
ure 1).
NRG1 is predicted to encode a protein of 231 amino acids
with two C2H2 zinc fingers in the carboxyl terminus. Se-
quence analysis revealed that the 2µ  plasmid that confers
suppression of snf2∆  encodes just the amino terminal re-
gion of Nrg1, lacking the zinc fingers. To test if the com-
plete  NRG1 gene causes the same high copy number
phenotype, we subcloned the complete NRG1 gene into a
2µ  plasmid and tested it for suppression of snf2∆ . Our re-
sults demonstrate that the complete NRG1 gene on a 2µ
plasmid does not suppress snf2∆  (Figure 1).
NRG1 encodes a repressor of transcription
To characterize further the role of Nrg1 with respect to
SUC2 transcription, we constructed and analyzed an
nrg1∆  mutant. The nrg1∆  mutant grows normally on me-
dia containing glucose, sucrose, or galactose, demon-
strating that NRG1 is not essential for grwoth and that
nrg1∆  mutants can utilize several different carbon sourc-
es.
To test for the requirement for Nrg1 in glucose repres-
sion, we tested growth of an nrg1∆  mutant on YP sucrose
media containing the glucose analog, 2-deoxyglucose (2-BMC Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2156/2/5
Figure 1
Overexpressing a truncated clone of NRG1 suppresses snf2∆ . Yeast strains FY32 (snf2∆ 1::HIS3 SUC2) and yHZ269
(snf2∆ 1::HIS3 SUC2-36) were transformed with nrgl∆ Zn or full-length NRG1 cloned in pRS426, as well as vector alone. Ura +
single colonies carrying each construct were resuspended in 200 µ l sterile water, and spotted on SC-Ura plates containing glu-
cose or raffinose as the carbon source. Plates were photographed on day 2.
Table 1: Yeast Strains
Strain Genotype
FY32 MATα  his3∆  200 snf2∆ 1::HIS3 ura3-52
FY1845 MAT a his3∆ 200 lys2-128δ  snf2∆ 1::HIS3 SUC2-36 ura3-52
FY1846 MAT a /MATα  his3∆ 200/HIS3 LEU2/leu2∆ 0 ura3∆ 0/ura3∆ 0
FY1847 MAT a his3∆ 200 leu2∆ 0 ura3∆ 0 nrg1∆ 1::URA3
FY1848 MATα  his3∆ 200 leu2∆ 0 lys2∆ 0 swp73∆ 1::LEU2 ura3∆ 0
FY1849 MAT a leu2∆ 0 snf1∆ 10
FY1850 MAT a his3∆ 200 leu2∆ 0 lys2∆ 0 snf1∆ 10 nrg1∆ 1::URA3 ura3∆ 0
FY1851 MAT a his3∆ 200 leu2∆ 0 met15∆ 0 snf2∆ 2::LEU2 ura3∆ 0
FY1852 MAT a ade8 his3∆ 200 leu2∆ 0 met15∆ 0 swi1∆ 1::LEU2 ura3∆ 0
FY1853 MAT a his3∆ 200 leu2∆ 0 lys2∆ 0 swp73∆ 1::LEU2 nrg1∆ 1::URA3 ura3∆ 0
FY1854 MAT a his3∆ 200 leu2∆ 0 snf2∆ 2::LEU2 ura3∆ 0 nrg1∆ 1::URA3
FY1855 MAT a his3∆ 200 leu2∆ 0 swilM::LEU2 nrg1∆ 1::URA3 ura3∆ 0
FY1856 MATα  his3∆ 200 leu2∆ 0 lys2-128δ  ura3∆ 0
FY1857 MATα  his3∆ 200 leu2∆ 0 lys2-128δ  mig1-∆ 2::LEU2 ura3∆ 0
FY1858 MAT a his3∆ 200 leu2∆ 0 lys2-128δ  mig2∆ 1::HIS3 ura3∆ 0 nrg1∆ 1::URA3
FY1859 MAT a his3∆ 200 leu2∆ 0 lys2-128δ  mig1-∆ 2::LEU2 nrg1∆ 1::URA3 ura3∆ 0
FY1860 MAT a his3∆ 200 leu2∆ 0 met15∆ 0 mig1-∆ 2::LEU2 mig2∆ 1::HIS3 nrg1∆ 1::URA3
ura3∆ 0
FY1861 MAT a his3∆ 200 leu2∆ 0 met15∆ 0 mig1-∆ 2::LEU2 mig2∆ 1::HIS3 ura3∆ 0
FY1862 MAT a his3∆ 200 leu2∆ 0 met15∆ 0 mig2∆ 1::HIS3 ura3∆ 0
FY1863 MAT a his3∆ 200 leu2∆ 0 lys2-128δ  mig1-∆ 2::LEU2 ura3∆ 0
FY1864 MAT a his3∆ 200 leu2∆ 0 lys2-128δ  mig1-∆ 2::URA3 snf2∆ 2::LEU2 ura3∆ 0
FY1865 MAT a his3∆ 200 leu2∆ 0 lys2-128δ  mig1-∆ 2::URA3 swi1∆ 1::LEU2 ura3∆ 0
FY1866 MAT a his3∆ 200 leu2∆ 0 lys2-128δ  mig1-∆ 2::URA3 swp73∆ 1::LEU2 ura3∆ 0
FY1867 MAT a his3∆ 200 leu2∆ 0 lys2-128δ  mig1-∆ 2::URA3 snf1∆ 10 ura3∆ 0
FY1868 MATα  his3∆ 200 leu2∆ 0 lys2-128δ  swi1∆ 1::LEU2BMC Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2156/2/5
DG). 2-DG causes glucose repression but cannot be used
as a carbon source by S. cerevisiae. Therefore, wild-type
cells do not grow on YP sucrose plates that contain 2-DG,
due to glucose repression of SUC2. However, strains de-
fective for glucose repression can grow on this medium
as they express SUC2 even in the presence of 2-DG. We
found that an nrg1∆  mutant was able to grow on YP su-
crose plus 2-DG, suggesting that nrg1∆  mutants are in-
deed defective for glucose repression. To assess the role
of Nrg1 relative to the two other factors known to be re-
quired for glucose repression, Mig1 and Mig2, we com-
pared the mutant phenotypes caused by nrg1∆ , mig1∆ ,
and mig2∆ , as well as testing combinations of these dele-
tions. We observed that the three single mutants grow
with different strengths on YP sucrose 2-DG plates in the
order mig1∆  > nrg1∆  > mig2∆  (Figure 2). The double and
triple mutants had stronger phenotypes than the single
mutants (Figure 2). These results strongly suggest that
Nrg1, Mig1, and Mig2 are each required for glucose re-
pression at the SUC2 locus, with Mig1 playing the major
role. We also tested growth of these strains on YP galac-
tose + 2-DG plates and found that only the triple mutant
was able to grow, albeit weakly, on this medium, perhaps
because galactose is a poor carbon source (data not
shown). This suggests that each of these three proteins
contributed to glucose repression of the GAL genes.
Glucose repression of transcription is defective in nrg1∆
To test whether the nrg1∆  phenotype on 2-DG plates is
caused by altered transcription, we performed Northern
analyses to SUC2 mRNA levels. Under repressing condi-
tions (2% glucose), the level of SUC2 mRNA was in-
creased by two-to-four fold in an nrg1∆  strain compared
to a wild-type control (Figure 3A). Consistent with previ-
ously published results, a mig1∆  mutant had a nine- to-
fourteen fold increase in SUC2 mRNA levels while a
mig2∆  mutant had no detectable defect in glucose re-
pression of SUC2 [4, 12]. We also analyzed the SUC2
Figure 2
Deletion of NRG1 partially abolishes glucose repression. nrg1∆  allows cells to grow on sucrose plates containing 2-
deoxyglucose, and has additive effects with mig1∆  and mig2∆ . A single colony of each strain was inoculated into liquid YPD and
grown to saturation (approx. 1 ×  108 cells/ml). The cultures were then diluted 1:2 (upper panels) or 1:5 (lower panels) in ster-
ile water, and spotted on YPD plates and YP sucrose plates with 200 µ g/ml 2-deoxyglucose. Plates were photographed on after
1 and 2 days of incubation at 30° C.BMC Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2156/2/5
mRNA levels in double and triple mutant combinations.
In general, multiple mutations caused greater derepres-
sion, up to 79-fold for the triple mutant, nrg1∆  mig1∆
mig2∆  (Figure 3A). These data demonstrate that Nrg1,
Mig1, and Mig2 all contribute to the glucose repression
of SUC2.
We also tested if an nrg1∆  affects glucose repression of
the GAL genes as described in Materials and Methods.
Both nrg1∆  and mig1∆  mutations cause a defect in the
glucose repression of GAL1 and GAL10, whereas mig2∆
alone had no effect (Figure 3B). As for SUC2, additive ef-
fects were observed in double and triple mutant strains,
up to a 13-fold effect for the nrg1∆  mig1∆  mig2∆  triple
mutant (Figure 3B). These data indicate that all three
proteins are involved in glucose repression of GAL1-
GAL10, with Mig2 playing only a minor role.
Deletion of MIG1 or NRG1 suppresses mutations in both 
SNF1 and SWI/SNF genes
Activation of SUC2 transcription depends upon both the
Snf1/Snf4 kinase complex and the Swi/Snf nucleosome
remodeling complex. To address the relationship of Nrg1
to both complexes and to compare it to Mig1, we tested
the abilities of nrg1∆  and mig1∆  to suppress the Gal-,
Suc-, and Raf- phenotypes of mutations in SNF1 and
SWI/SNF genes.
Our results (Figure 4) show that both nrg1∆  and mig1∆
suppress, albeit sometimes weakly, mutations in both
SNF1 and SWI/SNF genes. With respect to suppression
of snf1∆ , mig1∆  is the stronger suppressor, with suppres-
sion detectable for the Gal" phenotype (Figure 4A). The
observed suppression by mig1∆  is consistent with previ-
ous results [22]. The nrg1∆  mutation did not detectably
suppress either the Suc- or Raf- phenotypes caused by
snf1∆ . With respect to swi/snf mutations, we tested sup-
pression of both snf2∆  and swp73∆  and observed weak
suppression of the Gal- and Suc phenotypes (Figure 4B).
Suppression of the Raf- phenotype was not detectable.
There appear to be some gene-specific interactions as
suppression of swp73∆  by mig1∆  was stronger than the
suppression observed for the other pairs tested.
Discussion
Our results demonstrate that Nrg1 plays a role in glucose
repression of the SUC2 and GAL genes of S. cerevisiae.
Consistent with a role in glucose repression, an nrg1∆
mutation suppresses the defects of a snf1∆  mutant. Re-
cent results from an independent study have demon-
strated an interaction between Snf1 and Nrg1 [23]. Our
results also suggest that Nrg1 is partially redundant with
two other factors required for glucose repression, Mig1
and Mig2. At SUC2 and GAL1-10, all three proteins ap-
pear to be involved in glucose repression, because dou-
ble- and triple-deletion mutations have additive effects.
Interestingly, both nrg1∆  and mig1∆  can also suppress
the defects caused by mutations in genes encoding mem-
bers of the Swi/Snf complex.
While Nrg1, Mig1, and Mig2 are partially redundant, cur-
rent evidence suggestions that they do not function in the
same relative fashion at all glucose-repressible promot-
ers. For example, while mig1∆  and nrg1∆  cause compa-
rable defects at GAL1-GAL10, nrg1∆  causes a weaker
defect at SUC2. Mig2 appears to have only a minimal
function at either promoter. In addition, Nrg1 is the ma-
jor repressor at STA1, whose glucose-repression does not
require Mig1 [11]. Therefore, some gene-specific special-
ization exists among these three glucose-dependent re-
pressors.
A previous study of Nrg1 provided evidence that it inter-
acts with Ssn6 and confers repression by recruitment of
Ssn6/Tup1 [11]. We initially identified NRG1 in our stud-
ies by the isolation of a high-copy-number plasmid en-
coding a fragment of Nrg1, lacking the zinc-finger
domain. Likely, the phenotype caused by this plasmid is
caused by interference of repression by Ssn6/Tup1.
Our studies have not yet distinguished between a direct
or indirect effect of Nrg1 on glucose repression at SUC2
and GAL1-GAL10. One possible indirect effect of Nrg1
could be by regulation of MIG1 transcription. However,
Northern analysis showed that MIG1 mRNA levels are
unaffected by an nrg1∆  mutation (H. Zhou and F. Win-
ston, unpublished data). We tested Nrg1 for binding to
the SUC2 promoter and those experiments are briefly
summarized here. We screened for DNA binding of Nrg1
to the SUC2 promoter region using a previously de-
scribed GST-Nrg1 fusion protein [11] and a gel shift as-
say. Our results demonstrated specific DNA binding to
two sites within the -1022 to -825 region 5' of SUC2 (H.
Zhou and F. Winston, unpublished results). However, a
deletion of this region does not alter SUC2 expression.
Based on the similarity between the zinc fingers of Nrg1
and Mig1 and our binding studies, the binding site of
Nrg1 may contain a GC-rich core. Another such site in
the SUC2 promoter may occur at -570 with the sequence
AGGCCCA. Although we did not detect a gel shift of a
fragment containing this site, it is still possible that it is
recognized and bound by Nrg1 in vivo. Furthermore, al-
though an Nrg1 consensus binding [11] exists at -976 of
SUC2, we were unable to detect binding to this site by
GST-Nrg1. This region also did not compete the binding
that we detected by GST-Nrg1. This discrepancy between
our findings and previous results can be explained by the
fact that Park et al [11] used 10-fold more GST-Nrg1 in
their binding studies than we did. Finally, we did not de-BMC Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2156/2/5
Figure 3
Deletion of NRG1 causes defects in glucose repression. (A) A single colony of each strain was inoculated into YPD liq-
uid with 2% glucose and grown to mid-log phase (approx. 1 ×  107 cells/ml). The cells were harvested, and total RNA was iso-
lated and analyzed by electrophoresis followed by hybridization with probes specific to SUC2 or SPT15. The intensities of each
band was quantitated using phosphoimager and ImageQuant software. The amount of SUC2 mRNA in each strain was normal-
ized to SPT15, and the result obtained for the wild-type strain was assigned the arbitrary unit of 1.0 and used to calculate the
relative SUC2 mRNA levels in other strains. (B) Northern analysis of GAL1-10 mRNA in mutant strains. A single colony of each
strain was inoculated into SD complete liquid with 2% glucose+2% galactose and grown to mid-log phase. The cells were har-
vested, and total RNA was isolated from each and analyzed by electrophoresis followed by hybridization with probes specific
to GAL1, GAL10 or SPT15. Quantitation was carried out as for (A).BMC Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2156/2/5
tect any binding of Nrg1 to the Mig1 binding sites. Thus,
the DNA binding of Nrg1 to SUC2 remains to be resolved.
Conclusions
In conclusion, these studies have identified Nrg1 as a
third repressor required for glucose repression at SUC2
and the GAL genes. Based on the similarity between the
zinc fingers of Nrg1 and Mig1, the phenotypes of nrg1∆
and mig1∆ , and the reported interaction between Nrg1
and Ssn6 [11], Nrg1 likely functions by binding to the tar-
get promoters and recruiting the Ssn6/Tup1 complex.
The relative and possible cooperative roles of each of
these repressors in recruiting Ssn6-Tup1 remains to be
determined.
Materials and methods
Yeast strains
All S. cerevisiae strains are listed in Table 1 and are in the
S288C genetic background [25, 26]. Deletion of MIG1
was achieved by transforming strain yHZ416 with the
HindIII digest of pJN22 (for migl-∆ 2::LEU2) or pJN41
(for mig1-∆ 2::URA3) [4], and selecting for Leu+ or Ura+
transformants, respectively. PCR-directed gene replace-
ment [27] was used to construct deletions of NRG1 and
Figure 4
Mutations in SNF1 and SNF/SWI can be suppressed by both nrg1∆  and migl∆ . A single colony of each strain was inoc-
ulated into YPD liquid and grown over-night to saturation and adjusted in water to 1 ×  108 cells/ml. The cultures were then
diluted 1:2 in sterile water and spotted on YPD, YP galactose and YP sucrose plates, with uracil added to each plate to 80 µ M.
The first spot of each row represents a cell count of 5 ×  107 cells/ml, which is diluted 1:4 for the second spot and 1:2 for each
spot thereafter. YPD and YP sucrose plates were photographed after incubation at 30° C for 2 days, and YP galactose plates
were photographed after 5 days.BMC Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2156/2/5
MIG2. PCR reactions were carried out using as templates
pRS vectors carrying the desired markers [25, 28]. For
NRG1, the oligos used were HZ034, 5' TCG ACC AGC
ATA TTA CTA CCC TTC GCA AAC TTT CAG GCA CTG
TGC GGT ATT TCA CAC CG 3'; and HZ035, 5' GTA GTA
CTG CTA ATG AGA AAA ACA CGG GTA TAC CGT CAA
AGA TTG TAC TGA GAG TGC AC 3'. For MIG2, the oli-
gos were HZ045, 5' TGA CCT CGA GAA CAA ACA AAA
TAA AAA TAA AAA AAG AGA CTG TGC GGT ATT TCA
CAC CG 3'; and HZ046, 5' TTA GAG GAA AAA TGG TGA
GAT AAA AAG GGG CCG TAA AGG AGA TTG TAC TGA
GAG TGC AC 3'. The PCR fragment was used to trans-
form a haploid strain directly. All gene replacements
were verified by PCR, Southern analyses, and tetrad
analyses.
Media
The media used in this study were previously described
[29]. Glucose, galactose, sucrose or raffinose was added
to 2% final weight per volume. For solid media contain-
ing a carbon source other than glucose or glycerol, an-
timycin A was also added to a concentration of 1 µ g/ml.
To test for glucose repression of SUC2 and GAL genes, 2-
deoxyglucose was added to YP sucrose-antimycin A and
YP galactose-antimycin A plates to a final concentration
of 200 µ g/ml [4]. We discovered during the course of this
study that a ura3∆ 0 strain had half the amount of GAL 1-
10 mRNA of a URA3 strain when grown in SD media con-
taining 2% glucose and 2% galactose. A ura3∆ 0 strain
also grew more slowly than a URA3 strain on minimal
media containing sucrose or galactose. We do not yet
have an explanation for this phenomenon. To overcome
this growth defect, uracil was added to YP plates to a final
concentration of 80 µ M.
Subcloning of NRG1 constructs
The 1.8 kb SacI-SalI fragment of the original library
clone, containing only the 5' half of NrG1 without the zinc
fingers, was cloned into the SacI-SalI sites of pRS426 to
create pHZ56. To clone the complete NRG1 ORF, HZ032
and HZ033 were used to PCR from genomic DNA the
complete wild-type NRG1 from -1119 to +719. The PCR
fragment was digested with Sad and cloned into the
SacI-SmaI sites of pRS426 to generate pHZ52.
Northern analysis
Cell cultures were grown in liquid media as indicated to
mid-log phase (1-2 ×  l07 cells/ml), and total RNA was
prepared as previously described [27,30]. RNA was sep-
arated by electrophoresis on 1% agarose-formaldehyde
gels, transferred to membrane and blotted with specific
radio-labeled probes. The probes were: for SUC2, the 1.3
kb BamHI-HindIII fragment of pRB59 [31]; for GAL1-
10, the 2 kb EcoRI-EcoRI fragment of BNN45 [32] and
for SPT15, the 0.8 kb SpeI-HindIII fragment of pIP45 (I.
Pinto, personal communication). All probes were labeled
by random priming.
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